nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—peripheral nervous system neoplasm	0.397	1	CbGaD
Levetiracetam—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0596	0.15	CbGbCtD
Levetiracetam—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0556	0.14	CbGbCtD
Levetiracetam—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0547	0.138	CbGbCtD
Levetiracetam—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0456	0.115	CbGbCtD
Levetiracetam—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0456	0.115	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0373	0.0938	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0316	0.0794	CbGbCtD
Levetiracetam—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0194	0.0489	CbGbCtD
Levetiracetam—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0181	0.0456	CbGbCtD
Levetiracetam—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0178	0.0448	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0122	0.0306	CbGbCtD
Levetiracetam—Pain—Vincristine—peripheral nervous system neoplasm	0.000127	0.000617	CcSEcCtD
Levetiracetam—Constipation—Vincristine—peripheral nervous system neoplasm	0.000127	0.000617	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000617	CcSEcCtD
Levetiracetam—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000616	CcSEcCtD
Levetiracetam—Rash—Melphalan—peripheral nervous system neoplasm	0.000126	0.000615	CcSEcCtD
Levetiracetam—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000126	0.000615	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.000613	CcSEcCtD
Levetiracetam—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000125	0.00061	CcSEcCtD
Levetiracetam—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000609	CcSEcCtD
Levetiracetam—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000609	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000608	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000125	0.000606	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000601	CcSEcCtD
Levetiracetam—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000597	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000596	CcSEcCtD
Levetiracetam—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.000595	CcSEcCtD
Levetiracetam—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000592	CcSEcCtD
Levetiracetam—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000592	CcSEcCtD
Levetiracetam—Nausea—Topotecan—peripheral nervous system neoplasm	0.000122	0.000592	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000121	0.00059	CcSEcCtD
Levetiracetam—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000121	0.00059	CcSEcCtD
Levetiracetam—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000588	CcSEcCtD
Levetiracetam—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000121	0.000587	CcSEcCtD
Levetiracetam—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.000587	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000585	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000582	CcSEcCtD
Levetiracetam—Infection—Etoposide—peripheral nervous system neoplasm	0.000119	0.000581	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00058	CcSEcCtD
Levetiracetam—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.00058	CcSEcCtD
Levetiracetam—Nausea—Melphalan—peripheral nervous system neoplasm	0.000119	0.00058	CcSEcCtD
Levetiracetam—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000577	CcSEcCtD
Levetiracetam—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000577	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000574	CcSEcCtD
Levetiracetam—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000573	CcSEcCtD
Levetiracetam—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000118	0.000573	CcSEcCtD
Levetiracetam—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000571	CcSEcCtD
Levetiracetam—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000117	0.000571	CcSEcCtD
Levetiracetam—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000117	0.000571	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00057	CcSEcCtD
Levetiracetam—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000117	0.000568	CcSEcCtD
Levetiracetam—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000565	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000564	CcSEcCtD
Levetiracetam—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000115	0.000558	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000556	CcSEcCtD
Levetiracetam—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000555	CcSEcCtD
Levetiracetam—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000554	CcSEcCtD
Levetiracetam—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000114	0.000553	CcSEcCtD
Levetiracetam—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000552	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000552	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000551	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000548	CcSEcCtD
Levetiracetam—Pain—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000546	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000544	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000539	CcSEcCtD
Levetiracetam—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000538	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000536	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000533	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000533	CcSEcCtD
Levetiracetam—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000109	0.000532	CcSEcCtD
Levetiracetam—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.00053	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000528	CcSEcCtD
Levetiracetam—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000526	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000108	0.000525	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000525	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000523	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000522	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000107	0.00052	CcSEcCtD
Levetiracetam—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000106	0.000518	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000514	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000514	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000514	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000106	0.000514	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000513	CcSEcCtD
Levetiracetam—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.000513	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00051	CcSEcCtD
Levetiracetam—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000105	0.00051	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000104	0.000508	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000507	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000104	0.000505	CcSEcCtD
Levetiracetam—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000505	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000104	0.000504	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000501	CcSEcCtD
Levetiracetam—Pain—Etoposide—peripheral nervous system neoplasm	0.000103	0.0005	CcSEcCtD
Levetiracetam—Constipation—Etoposide—peripheral nervous system neoplasm	0.000103	0.0005	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000103	0.0005	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000103	0.0005	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000499	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000496	CcSEcCtD
Levetiracetam—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000496	CcSEcCtD
Levetiracetam—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000102	0.000494	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	9.99e-05	0.000486	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000485	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.000485	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000483	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000482	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.91e-05	0.000482	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.86e-05	0.00048	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.00048	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.83e-05	0.000478	CcSEcCtD
Levetiracetam—Dizziness—Vincristine—peripheral nervous system neoplasm	9.81e-05	0.000477	CcSEcCtD
Levetiracetam—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.79e-05	0.000476	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000476	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000476	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000476	CcSEcCtD
Levetiracetam—Rash—Alitretinoin—peripheral nervous system neoplasm	9.71e-05	0.000472	CcSEcCtD
Levetiracetam—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.7e-05	0.000472	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000472	CcSEcCtD
Levetiracetam—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.67e-05	0.00047	CcSEcCtD
Levetiracetam—Headache—Alitretinoin—peripheral nervous system neoplasm	9.65e-05	0.000469	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000464	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000463	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.5e-05	0.000462	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.5e-05	0.000462	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000462	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000462	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000461	CcSEcCtD
Levetiracetam—Vomiting—Vincristine—peripheral nervous system neoplasm	9.43e-05	0.000459	CcSEcCtD
Levetiracetam—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.41e-05	0.000458	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000458	CcSEcCtD
Levetiracetam—Rash—Vincristine—peripheral nervous system neoplasm	9.36e-05	0.000455	CcSEcCtD
Levetiracetam—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.35e-05	0.000455	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000453	CcSEcCtD
Levetiracetam—Headache—Vincristine—peripheral nervous system neoplasm	9.3e-05	0.000452	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.00045	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000449	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000446	CcSEcCtD
Levetiracetam—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.000445	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000444	CcSEcCtD
Levetiracetam—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.98e-05	0.000437	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000436	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000431	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.86e-05	0.000431	CcSEcCtD
Levetiracetam—Nausea—Vincristine—peripheral nervous system neoplasm	8.81e-05	0.000429	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000428	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.000427	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000424	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—peripheral nervous system neoplasm	8.62e-05	0.00042	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.00042	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000417	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.55e-05	0.000416	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—peripheral nervous system neoplasm	8.5e-05	0.000414	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000408	CcSEcCtD
Levetiracetam—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.34e-05	0.000406	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.000404	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000404	CcSEcCtD
Levetiracetam—Rash—Cisplatin—peripheral nervous system neoplasm	8.27e-05	0.000403	CcSEcCtD
Levetiracetam—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.27e-05	0.000402	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000402	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.22e-05	0.0004	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000399	CcSEcCtD
Levetiracetam—Tension—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000394	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.02e-05	0.00039	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000389	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—peripheral nervous system neoplasm	7.95e-05	0.000387	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000386	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000385	CcSEcCtD
Levetiracetam—Nausea—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.000379	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000379	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000377	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000374	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—peripheral nervous system neoplasm	7.64e-05	0.000372	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000372	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000369	CcSEcCtD
Levetiracetam—Rash—Etoposide—peripheral nervous system neoplasm	7.58e-05	0.000369	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.57e-05	0.000368	CcSEcCtD
Levetiracetam—Headache—Etoposide—peripheral nervous system neoplasm	7.53e-05	0.000366	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000365	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000361	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000361	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.00036	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.00036	CcSEcCtD
Levetiracetam—Cough—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000351	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.00035	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.000348	CcSEcCtD
Levetiracetam—Nausea—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.000347	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000342	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000342	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000342	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000342	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000341	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.00034	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000334	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000333	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000331	CcSEcCtD
Levetiracetam—Infection—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000326	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000324	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000322	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000322	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000321	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000318	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000316	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000316	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000316	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000315	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000314	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000313	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000306	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000301	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000299	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000298	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000297	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000297	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000295	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000294	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000291	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000289	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000289	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000285	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000283	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000283	CcSEcCtD
Levetiracetam—Pain—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.00028	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.00028	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000276	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000274	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000272	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.00027	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.00027	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000268	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000267	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000264	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000262	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000262	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000259	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000259	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000259	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000259	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.00025	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000248	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000242	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.00024	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.00024	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000235	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000232	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000224	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000224	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000218	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000217	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000215	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000208	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000208	CcSEcCtD
Levetiracetam—Rash—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000207	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.000207	CcSEcCtD
Levetiracetam—Headache—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000205	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000201	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000195	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000193	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000191	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000191	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.00019	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.00018	CcSEcCtD
